Vaxxas
Sarah Meibusch is a current Board Observer and Alternate Director at Vaxxas with experience as a Non Executive Director at Axial Therapeutics, Inc. and Nonexecutive Director at Life Sciences Queensland Limited.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Vaxxas
Needle-free vaccination and vaccine delivery solutions that safely and cost effectively amplify vaccine efficacy using Nanopatch technology developed by Vaxxas.